Literature DB >> 7666894

More frequent diagnosis of attention deficit-hyperactivity disorder.

J M Swanson, M Lerner, L Williams.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1995        PMID： 7666894     DOI： 10.1056/NEJM199510053331419

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  16 in total

1.  Methylphenidate in the United States, 1990 through 1995.

Authors:  R C Morrow; A L Morrow; G Haislip
Journal:  Am J Public Health       Date:  1998-07       Impact factor: 9.308

2.  Is attention deficit hyperactivity disorder increasing among girls in the US? Trends in diagnosis and the prescribing of stimulants.

Authors:  Linda M Robison; Tracy L Skaer; David A Sclar; Richard S Galin
Journal:  CNS Drugs       Date:  2002       Impact factor: 5.749

3.  mGlu5 in GABAergic neurons modulates spontaneous and psychostimulant-induced locomotor activity.

Authors:  Chia-Shan Wu; Christopher P Jew; Hao Sun; Carlos J Ballester Rosado; Hui-Chen Lu
Journal:  Psychopharmacology (Berl)       Date:  2019-10-24       Impact factor: 4.530

4.  Methylphenidate facilitates learning-induced amygdala plasticity.

Authors:  Kay M Tye; Lynne D Tye; Jackson J Cone; Evelien F Hekkelman; Patricia H Janak; Antonello Bonci
Journal:  Nat Neurosci       Date:  2010-03-07       Impact factor: 24.884

5.  Contrast of medical and nonmedical use of stimulant drugs, basis for the distinction, and risk of addiction: comment on Smith and Farah (2011).

Authors:  James M Swanson; Timothy L Wigal; Nora D Volkow
Journal:  Psychol Bull       Date:  2011-09       Impact factor: 17.737

6.  The extent of drug therapy for attention deficit-hyperactivity disorder among children in public schools.

Authors:  G B LeFever; K V Dawson; A L Morrow
Journal:  Am J Public Health       Date:  1999-09       Impact factor: 9.308

Review 7.  Psychostimulants and cognition: a continuum of behavioral and cognitive activation.

Authors:  Suzanne Wood; Jennifer R Sage; Tristan Shuman; Stephan G Anagnostaras
Journal:  Pharmacol Rev       Date:  2013-12-16       Impact factor: 25.468

Review 8.  Role of the dopamine transporter in the action of psychostimulants, nicotine, and other drugs of abuse.

Authors:  J Zhu; M E A Reith
Journal:  CNS Neurol Disord Drug Targets       Date:  2008-11       Impact factor: 4.388

Review 9.  Compliance with stimulants for attention-deficit/hyperactivity disorder: issues and approaches for improvement.

Authors:  James Swanson
Journal:  CNS Drugs       Date:  2003       Impact factor: 5.749

Review 10.  Attention-deficit hyperactivity disorder.

Authors:  Ajay K Thapar; Anita Thapar
Journal:  Br J Gen Pract       Date:  2003-03       Impact factor: 5.386
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.